News & Events

February 2020 –Cicero-Diagnostics-Awarded-1-Million-NIH-Grant

February 2018 – ReceptivaDx™ Test Now Being Used by over 150 IVF Centers Nationwide; CiceroDx, Inc. Adds Second US Laboratory Site to Meet Demand

November 14, 2017 – BusinessWire.com – BCL6 Biomarker Predicts IVF Success and Failure in Pivotal Study

June 6, 2017 – ‘Breakthrough’ Test for Unexplained Infertility Now Available

June 2020 – Infertility and Beyond! Cicero Diagnostics makes endometriosis easier to detect and helps resolve infertility issues even when IVF isn’t the answer

February 2019 – New Clinical Study Further Validates Use of ReceptivaDx™ (BCL6) Testing for Women with Unexplained Infertility by Demonstrating Successful Treatment Outcomes, Improved Live Birth Rates and Reduced Miscarriage Rates

December 2017 – 2017: A Progress Report

December 2017 – What is Endometriosis?

November 2017 – BCL6 Levels Can Predict Low IVF Success Rates

October 2017 – WWFM: Stealth endo conquered by IVF+ICSI, PGS, ERAx3, ReceptivaDX, Depot Lupron, Intralipid

June 9, 2017 – SheKnows.com – The Breakthrough Option for Treating Unexplained Infertility

March 25-29, 2020 – Pacific Coast Reproductive society –  Renaissance Esmeralda Resort & Spa, Indian Wells, CA – https://www.pcrsonline.org/2020-annual-meeting

May 1 – 2, 2020 – New England Fertility Society – Gurney’s Hotel, Newport, RI –https://www.nefs.org/2020annualmeeting.htm

June 3 – 6, 2020 – Midwest Reproductive Symposium International – Chicago, IL – http://www.midwestreproductivesymposium.com

October 17 – 21, 2020 – American Society of Reproductive Medicine (ASRM)- Portland, OR – https://www.asrm.org/events/upcoming-meetings/events/2020-10-17/